FDA Inspection 1155105 — Johnson Memorial Cancer Center

Johnson Memorial Cancer Center — FEI 3010955218

The FDA completed an inspection of Johnson Memorial Cancer Center on October 21, 2021 in Enfield, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 21, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Enfield, CT (United States)

Citations

IDCFRDescription
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
18963FDCA 501(a)(2)(A)Inadequate HEPA filter, sterile product area
18973FDCA 501(a)(2)(A)Disinfecting materials, aseptic processing area